Company profile
Ticker
TSBX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
832909368
TSBX stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
22 Apr 24
DEFA14A
Additional proxy soliciting materials
22 Apr 24
DEF 14A
Definitive proxy
22 Apr 24
8-K
Departure of Directors or Certain Officers
16 Apr 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
21 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
1 Sep 23
S-8
Registration of securities for employees
25 Jul 23
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Cash on hand (at last report) | 38.89 mm | 38.89 mm | 38.89 mm | |||
Cash burn (monthly) | (no burn) | 6.31 mm | (no burn) | |||
Cash used (since last report) | n/a | 43.75 mm | n/a | |||
Cash remaining | n/a | -4.86 mm | n/a | |||
Runway (months of cash) | n/a | -0.8 | n/a |
Institutional ownership, Q1 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Waddill William D. | Stock Option Common Stock | Grant | Acquire A | No | No | 2.81 | 25,540 | 71.77 k | 25,540 |
16 Oct 23 | Venkat Ramanan | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.61 | 46,606 | 121.64 k | 46,606 |
16 Oct 23 | Kanya Rajangam | Stock Option Common Stock | Grant | Acquire A | No | No | 2.61 | 8,012 | 20.91 k | 8,012 |
Press releases
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
21 Mar 24
Turnstone Biologics to Participate in Upcoming Investor Conferences
21 Feb 24
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
20 Feb 24